Curdlan sulfate

N/A

Report date: 2022/11/25 17:28:45
NME

Base Information

Drug NameCurdlan sulfate
Drug Alias Name硫酸多糖CRDS
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsHIV InfectionsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAjinomoto Co IncAji Pharma Usa Inc
Active IndicationsN/A
Inactive IndicationsHIV InfectionsMalaria

Other Information

ATC CodeN/A
Related LinksN/A